Natural Capsules Limited (BSE: 524654)
Health Care · Pharmaceuticals · IN
Rs152.40
+1.43% today · -22.7% 1Y
Natural Capsules Limited (BSE: 524654) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $16.76M.
Over the last twelve months the share price has lost 22.7%, trading between 137.50 and 296.40.
Tweenvest scores Natural Capsules Limited across four factors: quality 55/100, value 55/100, growth 52/100. Its strongest factor is quality.
524654 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.76M
- Revenue (TTM)
- $20.17M
- P/E
- —
- EPS
- -24.14
- Dividend yield
- —
- Beta (5Y)
- -0.07
- 52-week high
- Rs296.40
- 52-week low
- Rs137.50
- Avg volume (3M)
- —
- Shares outstanding
- 10.52M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,248.37 | +0.12% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.28 | -0.64% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.36 | +0.46% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.80 | +0.11% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.